Faeth Therapeutics, Inc. (FTH) Form 10-Q Quarterly Reports
Faeth Therapeutics, Inc. (FTH) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: FTH
CIK: 1829802
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerTheodore Mangan
Audit LocationBaltimore, Maryland, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-17 | 2026-09-11 | 8-K | 0001193125-26-394360 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | 4 Filing | 0001723884-26-000005 | View SEC Doc Filr Page |
| 3 | 2026-09-15 | 2026-09-11 | 3 Filing | 0001723884-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001727492-26-000018 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001493152-26-038381 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001193125-26-352288 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-096753 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001959173-26-005879 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001193125-26-331562 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001193125-26-331563 | View SEC Doc Filr Page |
| 3 | 2026-07-28 | 2026-06-15 | 3 | 0001193125-26-321026 | View SEC Doc Filr Page |
| 8-K | 2026-07-23 | 2026-07-21 | 8-K | 0001193125-26-314591 | View SEC Doc Filr Page |
| 4 | 2026-07-23 | 2026-07-21 | 4 Filing | 0002038400-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-23 | 2026-07-21 | 4 Filing | 0002111813-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | 4 Filing | 0001780030-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | 4 Filing | 0001780030-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | 4 Filing | 0001780030-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | 4 Filing | 0002111813-26-000010 | View SEC Doc Filr Page |
| 3 | 2026-06-23 | 2026-06-13 | 3 Filing | 0001780030-26-000003 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-23 | — | SCHEDULE 13G Filing | 0000899140-26-000676 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-23 | — | SCHEDULE 13G Filing | 0001193125-26-279412 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-15 | 8-K | 0001193125-26-276093 | View SEC Doc Filr Page |
| S-3ASR | 2026-06-18 | — | S-3ASR | 0001193125-26-275791 | View SEC Doc Filr Page |
| 4 | 2026-06-16 | 2026-06-12 | 4 Filing | 0001547959-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-06-16 | 2026-06-15 | 4 Filing | 0002111813-26-000009 | View SEC Doc Filr Page |